Loading…
5 companies · GEL, thousands · columns ordered by revenue
Only 3 of 5 peers filed FY2024. Switch to FY2023 (4 of 5).
| Line item | Molekuluri Diagnostikis… | Mtskhetis Pirveladi Jan… | Apkhazetidan Idzulebit … | N Kiron + | Balneo Sareabilitatsio … |
|---|---|---|---|---|---|
| Total Revenue | 1,031 | 996 | 975 | — | — |
| Total COGS | -227 | 0 | -204 | — | — |
| Gross Profit | 805 | 996 | 771 | — | — |
| Gross Margin | 78.0% | 100.0% | 79.1% | — | — |
| Total Operating Expenses | -934 | -509 | -736 | — | — |
| EBITDA | -129 | 487 | 35 | — | — |
| EBITDA Margin | -12.6% | 48.9% | 3.6% | — | — |
| Total D&A | -119 | -30 | -38 | — | — |
| EBIT / Operating Income | -248 | 457 | -3 | — | — |
| Total Interest Income | 0 | 19 | — | — | — |
| Total Other Income | -0 | — | — | — | — |
| Profit Before Tax | -248 | 476 | -3 | — | — |
| Total Income Tax | 0 | 0 | 0 | — | — |
| Net Profit / (Loss) | -130 | 476 | -3 | — | — |
| Net Margin | -12.6% | 47.8% | -0.3% | — | — |
Not every picked company reports every selected year — FY2024: no filing for N Kiron + and Balneo Sareabilitatsio …. Those cells are left blank (no filing), not zero.
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Mtskhetis Pirveladi Jan… | Healthcare Services | 48.9% | 97th pct | 268 |
| Apkhazetidan Idzulebit … | Healthcare Services | 3.6% | 30th pct | 268 |
| Molekuluri Diagnostikis… | Healthcare Services | -12.6% | 12th pct | 268 |
| N Kiron + | Healthcare Services | — | no FY data | 268 |
| Balneo Sareabilitatsio … | Healthcare Services | — | no FY data | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.